Women’s Leadership Development Program Class of 2021 welcomed by ARVO

Article

The Association for Research in Vision and Ophthalmology recognizes their latest cohort to complete the Women Leadership Development Program.

Women’s Leadership Development Program Class of 2021 welcomed by ARVO

In early September, the Association for Research in Vision and Ophthalmology (ARVO) recognized the Class of 2021 from their Women’s Leadership Development Program (WLDP). These women completed a year-long educational experience, aimed to hone leadership skill for women in ophthalmology.

The Class of 2021 of the ARVO Women’s Leadership Development Program:

  • Carol Cheung, PhD, The Chinese University of Hong Kong, China
  • Lauren Dalvin, MD, Mayo Clinic
  • Samantha Dando, PhD, Queensland University of Technology, Australia
  • Marie-Helene Errera, MD, PhD, UPMC Eye Center, Pittsburgh Medical School
  • Aakriti Garg Shukla, MD, Wills Eye Hospital/Thomas Jefferson University
  • Yao Liu, MD, University of Wisconsin-Madison
  • Hua Mei, PhD, University of North Carolina at Chapel Hill
  • Alexandra Miere, MD, Centre Hospitalier Intercommunal De Créteil, France
  • Freya Mowat, PhD, DVM, University of Wisconsin-Madison
  • Kristen Nwanyanwu, MD, Yale University
  • Tawna Roberts, PhD, OD, Stanford University
  • Jessica Shantha, MD, Emory University
  • Victoria Tseng, MD, PhD, University of California Los Angeles
  • Mary Whitman, MD, PhD, Boston Children's Hospital/Harvard Medical School
  • Jia Yin, MD, PhD, Harvard Medical School/ Massachusetts Eye and Ear

The Women’s Leadership Development Program provides a highly interactive, year-long educational experience with a focus on leadership skill development, facilitating leadership opportunities and networking within ARVO. The program was developed in 2016 to create an opportunity for emerging women leaders within the ARVO membership.

Early- to mid-career female scientists who are in a faculty/tenure-track (or equivalent) position for not more than 10 years and who have been ARVO members for at least 3 years are encouraged to apply. Each year, the program hosts 9-12 participants and their mentors (both men and women).

“Participation in this program will provide lifetime leadership skills that extend beyond ARVO for any early career female scientist,” says 2020 WLDP graduate Krista Kelly, PhD, director of the Vision and Neurodevelopment Laboratory, Retina Foundation of the Southwest. “This program was highly engaging, with discussions on important and often tough topics, coupled with individual mentorship. I feel I'm in a better place in terms of leading my lab, seeking out leadership opportunities, and forging collaborations for research than before.”

ARVO is currently accepting applications for the WLDP’s Class of 2022. The application window closes on October 31. To apply, visit the ARVO Women’s Leadership Development Program website.

Reference
ARVO Women's Leadership Development Program welcomes Class of 2021. The Association for Research in Vision and Ophthalmology. https://www.arvo.org/About/press-room/press-room/arvo-womens-leadership-program-welcomes-2021-class/. Accessed September 23, 2021.
Recent Videos
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
© 2024 MJH Life Sciences

All rights reserved.